Risks of side effects and safety monitoring recommendations for long-term use of Leborexan (Daveco)

Lemborexant is an oral dual oxygen receptor antagonist (DORA), mainly used to treat adult patients with difficulty falling asleep or maintaining sleep disorders. By selectively blocking Orexin-1 and Orexin-2 receptors in the central nervous system, leborexan can inhibit the conduction of arousal signals, thereby helping patients improve the time it takes to fall asleep, prolong total sleep duration, and improve sleep quality. Although its efficacy is significant, long-term use may still be associated with certain risks of side effects, which requires scientific monitoring and individualized management in clinical application.

The most common side effects of Leborex anagen use are daytime drowsiness and fatigue. Because its mechanism of action involves the central arousal system, some patients may experience reduced daytime attention, slow reaction, drowsiness, or affected executive functions after taking the drug at night. Such symptoms are particularly common in older patients and may increase the risk of falls, traffic accidents, or accidents during daily activities. Therefore, during long-term use, patients should pay attention to adjusting their schedule and avoid driving or operating dangerous machinery immediately after taking medication at night. Doctors should also regularly assess the patient's daytime functional status and adjust the dosage or medication time according to the actual situation.

Leborexan may cause cognitive and psychiatric adverse reactions, such as abnormal dreams, mild hallucinations, or mood swings. Although severe cognitive impairment is rare, long-term use should be cautious in patients with existing mental illness or cognitive decline. It is clinically recommended to assess the patient's mental and cognitive status before medication and to follow up regularly during treatment. If there are obvious mood changes, anxiety, depression or memory impairment, the doctor should be informed in time, and the dosage should be adjusted or medication suspended if necessary. In addition, leborexan has not yet shown serious addiction, but long-term use still requires attention to potential tolerance and dependence risks, and patients should avoid increasing the dose on their own or overusing it for a long time.

Leborexan may affect liver function and drug metabolism. It is mainly metabolized by CYP3A4enzyme. Therefore, when used simultaneously with potent CYP3A4 inhibitors or inducers, it may cause the blood concentration to increase or decrease, increase adverse reactions or reduce efficacy. Patients with hepatic insufficiency need special attention when taking long-term medication. It is recommended to conduct liver function tests before starting treatment and regularly monitor blood biochemical indicators during medication. At the same time, the combined use of other central depressants (such as benzodiazepines or sedative-hypnotics) may also increase the risk of excessive sedation or respiratory depression, and the combined medication regimen needs to be adjusted under the guidance of a doctor.

To ensure the safety of long-term medication, it is clinically recommended to adopt a systematic monitoring program. Before taking medication, patients should be informed in detail of their past medical history, past medication and concomitant diseases, and their liver function, kidney function, blood pressure and daytime sleepiness or cognitive function status should be reviewed regularly. At the same time, a sleep diary should be recorded to evaluate the time it takes to fall asleep, the number of night awakenings and the total sleep duration so that doctors can judge the efficacy and adjust the dose. For older patients or those with multiple comorbidities, safety should be assessed more frequently and dose reduction or intermittent use should be considered if necessary. Through scientific monitoring, individualized management and standardized follow-up, leborexan can maintain good sleep improvement effects during long-term use, while minimizing the risk of side effects and providing patients with safe and effective sleep intervention.

Reference link:https://www.drugs.com